IOL Chemicals & Pharmaceuticals has received ‘certificates of pharmaceuticals products’ (COPP) for manufacturing of drugs --Ibuprofen IP/BP/USP/Ph.Eur./JP and Lamotrigine IP/BP/USP/Ph.Eur from Food & Drugs Administration, Punjab. This product will be manufacture in its exiting Multiple Purpose Plant conforming to the WHO guidelines. This will facilitate the company to broaden its presence in export market.
Ibuprofen is, a non-steroidal anti-inflammatory drug (NSAID), used for the treatment of various types of pains and Lamotrigine is, an anti-convulsant drug, used for the treatment of epileptic seizures . The company is already having US Food and Drug Administration (USFDA) and European Directorate for the Quality of Medicines & HealthCare (EDQM) approved Ibuprofen manufacturing facilities.
IOL Chemicals & Pharmaceuticals is one of the largest manufacturers of APIs and specialty chemicals with presence in over 57 countries across the world. It manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, textile, packaging, lamination, pesticides and food processing applications.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: